Tokyo, Japan

Fumie Narazaki



 

Average Co-Inventor Count = 11.0

ph-index = 3

Forward Citations = 65(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Fumie Narazaki: Pioneering Solutions in Urology

Introduction

Fumie Narazaki, an inventive force based in Tokyo, Japan, has made significant strides in the field of pharmaceutical development. With a total of three patents to her name, Narazaki has focused her efforts on creating solutions that address urinary disorders, showcasing her commitment to improving patient quality of life.

Latest Patents

Among Narazaki's latest patents is the pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate compound, which has garnered attention for its potent FAAH-inhibitory activity. This innovative compound and its pharmaceutically acceptable salts are applicable in treating urinary frequency, urinary incontinence, overactive bladder, and associated pain. The patent describes how this novel derivative can enhance effective bladder capacity while alleviating symptoms of urinary frequency and exerting an anti-allodynia effect, demonstrating its potential as a valuable therapeutic option.

Another notable patent focuses on providing a compound usable for the treatment of diseases connected to fatty acid amide hydrolase (FAAH). This reflects her dedication to developing medicines that effectively address pressing medical needs, particularly focusing on conditions that significantly affect daily living and comfort.

Career Highlights

Fumie Narazaki currently works with Astellas Pharma, a renowned pharmaceutical company dedicated to improving healthcare through innovative research and development. Her work is characterized by a focus on creating therapies that target specific medical challenges, particularly those related to urology.

Collaborations

In her career, Narazaki has collaborated with talented colleagues, including Takahiro Ishii and Takashi Sugane. These partnerships have allowed her to blend ideas and expertise, enhancing the innovation process and resulting in effective medical solutions.

Conclusion

Fumie Narazaki stands out as a prominent innovator in the pharmaceutical industry, particularly in the realm of urology. Her contributions not only highlight her inventive spirit but also reflect a broader commitment to enhancing the lives of individuals facing challenging health issues. As researchers and companies continue to seek novel approaches, Narazaki's work undoubtedly provides a crucial stepping stone for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…